212 related articles for article (PubMed ID: 2422137)
1. 3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.
Moriconi WJ; Slavik M; Taylor S
Invest New Drugs; 1986; 4(1):67-84. PubMed ID: 2422137
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside.
Chabot GG; Bouchard J; Momparler RL
Biochem Pharmacol; 1983 Apr; 32(7):1327-8. PubMed ID: 6189497
[No Abstract] [Full Text] [Related]
3. Enzyme pattern-directed chemotherapy: synergistic interaction of 3-deazauridine with D-galactosamine.
Jackson RC; Williams JC; Weber G
Cancer Treat Rep; 1976 Jul; 60(7):835-43. PubMed ID: 188552
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
Brockman RW; Shaddix SC; Williams M; Nelson JA; Rose LM; Schabel FM
Ann N Y Acad Sci; 1975 Aug; 255():501-21. PubMed ID: 171997
[TBL] [Abstract][Full Text] [Related]
5. Cytidine and deoxycytidylate deaminase inhibition by uridine analogs.
Drake JC; Hande KR; Fuller RW; Chabner BA
Biochem Pharmacol; 1980 Mar; 29(5):807-11. PubMed ID: 20227960
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic and biochemical effects of thymidine and 3-deazauridine on human tumor cells.
Lockshin A; Mendoza JT; Giovanella BC; Stehlin JS
Cancer Res; 1984 Jun; 44(6):2534-9. PubMed ID: 6722792
[TBL] [Abstract][Full Text] [Related]
7. Toxicity of combinations of arabinosylcytosine and 3-deazauridine toward neoplastic cells in culture.
Mills-Yamamoto C; Lauzon GJ; Paterson AR
Biochem Pharmacol; 1978 Jan; 27(2):181-6. PubMed ID: 623673
[No Abstract] [Full Text] [Related]
8. Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts.
Grant S; Cadman E
Cancer Res; 1980 Nov; 40(11):4000-6. PubMed ID: 6162541
[TBL] [Abstract][Full Text] [Related]
9. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
Li ZR; Campbell J; Rustum YM
Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of anti-neoplastic activity of cytosine arabinoside against human HL-60 myeloid leukemic cells by 3-deazauridine.
Momparler RL; Bouffard DY; Momparler LF; Marquet J; Zittoun J; Marie JP; Zittoun R
Int J Cancer; 1991 Oct; 49(4):573-6. PubMed ID: 1917159
[TBL] [Abstract][Full Text] [Related]
11. Labelling of the thymidine and deoxycytidine bases of DNA by [2-14C]deoxycytidine in cultured L1210 cells.
Karle JM; Hoerauf RM; Cysyk RL
Cancer Lett; 1983 Jun; 19(2):147-57. PubMed ID: 6883305
[TBL] [Abstract][Full Text] [Related]
12. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
Momparler RL; VeselĂ˝ J; Momparler LF; Rivard GE
Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
[TBL] [Abstract][Full Text] [Related]
13. Enzyme pattern-directed chemotherapy. Effects of antipyrimidine combinations on the ribonucleotide content of hepatomas.
Lui MS; Jackson RC; Weber G
Biochem Pharmacol; 1979 Apr; 28(7):1189-95. PubMed ID: 444276
[No Abstract] [Full Text] [Related]
14. Transport of uridine and 3-deazauridine in cultured human lymphoblastoid cells.
Dahlig-Harley E; Paterson AR; Robins MJ; Cass CE
Cancer Res; 1984 Jan; 44(1):161-5. PubMed ID: 6580947
[TBL] [Abstract][Full Text] [Related]
15. 3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase.
Raynal NJ; Momparler LF; Rivard GE; Momparler RL
Leuk Res; 2011 Jan; 35(1):110-8. PubMed ID: 20510451
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and 3-deazauridine 5'-triphosphate in human leukemia cells by high-performance liquid chromatography.
Plunkett W; Chubb S; Barlogie B
J Chromatogr; 1980 Dec; 221(2):425-30. PubMed ID: 6938519
[No Abstract] [Full Text] [Related]
17. Regulation of pyrimidine biosynthesis in cultured L1210 cells by 3-deazauridine.
Karle JM; Cysyk RL
Biochem Pharmacol; 1984 Dec; 33(23):3739-42. PubMed ID: 6095859
[TBL] [Abstract][Full Text] [Related]
18. Cytidine 5'-triphosphate synthetase as a target for inhibition by the antitumor agent 3-deazauridine.
McPartland RP; Wang MC; Bloch A; Weinfeld H
Cancer Res; 1974 Nov; 34(11):3107-11. PubMed ID: 4472653
[No Abstract] [Full Text] [Related]
19. Cell cycle arrest as a basis of enhancement of 1-beta-D-arabinofuranosylcytosine anabolism in human lymphoblastoid RPMI 6410 cells cultured with 3-deazauridine.
Lauzon GJ; Yang S; Paterson AR
Biochem Pharmacol; 1981 Jul; 30(14):1889-94. PubMed ID: 6895033
[No Abstract] [Full Text] [Related]
20. In vivo cellular kinetic and pharmacological studies of 1-beta-D-arabinofuranosylcytosine and 3-deazauridine chemotherapy for relapsing acute leukemia.
Barlogie B; Plunkett W; Raber M; Latreille J; Keating M; McCredie K
Cancer Res; 1981 Mar; 41(3):1227-35. PubMed ID: 7459863
[No Abstract] [Full Text] [Related]
[Next] [New Search]